yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q52654614-B967E7C2-C001-499B-BD19-7D78E875FC82
Q52654614-B967E7C2-C001-499B-BD19-7D78E875FC82
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52654614-B967E7C2-C001-499B-BD19-7D78E875FC82
Current therapeutic molecules and targets in neurodegenerative diseases based on in silico drug design.
P2860
Q52654614-B967E7C2-C001-499B-BD19-7D78E875FC82
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52654614-B967E7C2-C001-499B-BD19-7D78E875FC82
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c707a2721fe83a13a7e110379a2e727d0fb7e6a0
P2860
In silico, in vitro and cellular analysis with a kinome-wide inhibitor panel correlates cellular LRRK2 dephosphorylation to inhibitor activity on LRRK2.